NSN 6505-01-252-0802 NDC00047045130, NDC00047-0451-30, NDC00074438953
Product Details | USP CLORAZEPATE DIPOTASSIUM TABLETS
6505-01-252-0802 00001016505000000
Part Alternates: NDC00047045130, NDC00047-0451-30, NDC00074438953, NDC00074-4389-53, NDC00228306750, NDC00228-3067-50, NDC00364220105, NDC00364-2201-05, NDC00378003005, NDC00378-0030-05, NDC00536494005, NDC00536-4940-05, NDC00591036305, NDC00591-0363-05, NDC51672404202, NDC51672-4042-02, NDC53265004850, NDC53265-0048-50, TRANXENE, TRANXENE TABLETS, TRANXENETABLETS, 438953, 4389-53, 6505-01-252-0802, 01-252-0802, 6505012520802, 012520802
Medical, Dental, and Veterinary Equipment and Supplies | Drugs and Biologicals
| Supply Group (FSG) | NSN Assign. | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | 29-MAR-87 | 01-252-0802 | 66760 ( CLORAZEPATE DIPOTASSIUM TABLETS, USP0 ) |
Cross Reference | NSN 6505-01-252-0802
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 4389-53 | 70048 | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
| NDC00047-0451-30 | 2T119 | WARNER LAMBERT LTD |
| NDC00074-4389-53 | 70048 | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
| NDC00228-3067-50 | 56287 | ACTAVIS, INC |
| NDC00364-2201-05 | 64682 | SCHEIN HENRY INC |
| NDC00378-0030-05 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC00536-4940-05 | 4V824 | RUGBY GROUP INC |
| NDC00591-0363-05 | 62051 | DANBURY PHARMACAL INC |
| NDC51672-4042-02 | 0MLD2 | TARO PHARMACEUTICALS USA INC |
| NDC53265-0048-50 | 0E5C1 | ABLE LABORATORIES |
| TRANXENE | 70048 | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
| TRANXENE TABLETS | 70048 | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
Request a Quote
What Our Customers Say
Thank you very much for the excellent service and professional customer care.
The service was excellent. I can think of no improvements to date that you can make regarding internet sales.
The representative for WBParts was efficient & handled our request in a timely & professional manner.
Tried two other sources, neither of them responded, was all done online, never spoke to anyone.
The response is quick and the price is often very good. We are completely satisfied.
Compare
Related Products | NSN 6505-01-252-0802
Technical Data | NSN 6505-01-252-0802
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| III PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
Restrictions/Controls & Freight Information | NSN 6505-01-252-0802
| Category | Code | Description |
|---|---|---|
| Shelf-Life Code: | M | 24 months |
| Hazardous Material Indicator Code | P | There is no information in the HMIS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product |
| Demilitarization Code: | A | Non-Munitions List Item/ Non-Strategic List Item - Demilitarization not required. |
| Controlled Inventory Item Code: | Q | A DRUG OR OTHER CONTROLLED SUBSTANCE DESIGNATED AS A SCHEDULE III, IV, OR V ITEM, IN ACCORDANCE WITH THE CONTROLLED SUBSTANCE ACT OF 1970. OTHER SENSITIVE ITEMS REQUIRING LIMITED ACCESS STORAGE./  |
| Precious Metals Indicator Code: | A | Item does not contain precious metal |
| Criticality Code: | X | The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. |
| Category | Code | Description |
|---|---|---|
| No Freight Information | ||